Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 932 of 1,261

  1. US 8124084

    Compositions and methods for immunomodulation in an organism using IL-15 and soluble IL-15Ra

    UNIVERSITY OF CONNECTICUT · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  2. US 8124781

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  3. US 8124584

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  4. US 8124058

    Artificial nail compositions and related methods

    Creative Nail Design Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  5. US 8124059

    Stabilized aqueous aluminum zirconium solutions

    Summit Research Labs, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  6. US 8123541

    Electrical connector with expanded cover

    Hon Hai Precision Ind. Co., Ltd. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  7. US 8124669

    Dental composition

    Kuraray Medical Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  8. US 8124109

    Vault compositions for immunization against chlamydia genital infection

    The Regents of the University of California · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  9. US 8124068

    Recombinant intracellular pathogen immunogenic compositions and methods of use

    The Regents of the University of California · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  10. US 8124105

    Compositions, methods and kits relating to poxvirus subunit vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  11. US 8124110

    Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species

    The Regents of the University of California · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  12. US 8124120

    Crosslinked hyaluronic acid compositions for tissue augmentation

    ANIKA THERAPEUTICS, INC. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  13. US 8124579

    Heat shock protein 20-related polypeptides and uses therefor

    THE ARIZONA BOARD OF REGENTS · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  14. US 8124127

    Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings

    ATRIUM MEDICAL CORPORATION · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  15. US 8124583

    Composition and method for self-assembly and mineralization of peptide-amphiphiles

    Northwestern University · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  16. US 8124592

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  17. US 8124766

    Inhibitors of diacylglycerol acyltransferase

    Madrigal Pharmaceuticals, Inc. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  18. US 8124606

    Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones

    Takeda Pharmaceutical Company Limited · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  19. US 8124644

    Carvedilol phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  20. US 8124651

    Palmarumycin based inhibitors of thioredoxin and methods of using same

    THE ARIZONA BOARD OF REGENTS · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  21. US 8124617

    Imidazopyridine compounds

    Takeda Pharmaceutical Company Limited · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  22. US 8124653

    Methods and compositions for the treatment of attention deficit hyperactivity disorder and hyperphenylalanemia

    The Board of Regents of the University of Texas System · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  23. US 8124802

    MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity

    Jenrin Discovery, LLC · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

  24. US 8125225

    Transmit profile control in MRI

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2012 · Expires Feb 23, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.